Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Capital Employed: 2022-2025

Historic Return on Capital Employed for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to -693.69%.

  • Molecular Partners Ag's Return on Capital Employed fell 22225.00% to -693.69% in Q3 2025 from the same period last year, while for Sep 2025 it was -693.69%, marking a year-over-year decrease of 22225.00%. This contributed to the annual value of 5.77% for FY2024, which is 147.00% up from last year.
  • Molecular Partners Ag's Return on Capital Employed amounted to -693.69% in Q3 2025, which was down 5.72% from -656.17% recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Return on Capital Employed peaked at 487.92% during Q1 2023, and registered a low of -693.69% during Q3 2025.
  • Over the past 3 years, Molecular Partners Ag's median Return on Capital Employed value was -407.47% (recorded in 2024), while the average stood at -162.13%.
  • As far as peak fluctuations go, Molecular Partners Ag's Return on Capital Employed surged by 64,917bps in 2023, and later crashed by 91,237bps in 2024.
  • Molecular Partners Ag's Return on Capital Employed (Quarterly) stood at -6.98% in 2022, then surged by 1,217bps to 5.19% in 2023, then surged by 126bps to 6.46% in 2024, then tumbled by 22,225bps to -693.69% in 2025.
  • Its last three reported values are -693.69% in Q3 2025, -656.17% for Q2 2025, and -492.75% during Q1 2025.